King Star Capital is a US dollar venture fund managed by Kington Capital which invests in bio-pharmaceutical companies in China.
King Star Capital is a USD dollar venture fund managed by Kington Capital. The fund focuses on investments in bio-pharmaceutical companies in China.
King Star Capital has made investments in Gracell Biotechnologies, MabSpace Biosciences, CStone Pharmaceuticals and Adagene.
They have exited their investments in CStone Pharmaceuticals and MabSpace Biosciences.
King Star Capital is a US dollar venture fund managed by Kington Capital which invests in bio-pharmaceutical companies in China.
King Star Capital is a USD dollar venture fund managed by Kington Capital. The fund focuses on investments in bio-pharmaceutical companies in China.
King Star Capital has made investments in Gracell Biotechnologies, MabSpace Biosciences, CStone Pharmaceuticals and Adagene.
They have exited their investments in CStone Pharmaceuticals and MabSpace Biosciences.
King Star Capital is a US dollar venture fund managed by Kington Capital which invests in bio-pharmaceutical companies in China.